GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Greenbrook TMS Inc (OTCPK:GBNHF) » Definitions » Research & Development

Greenbrook TMS (Greenbrook TMS) Research & Development : $0.54 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Greenbrook TMS Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Greenbrook TMS's Research & Development for the three months ended in Mar. 2024 was $0.12 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was $0.54 Mil.


Greenbrook TMS Research & Development Historical Data

The historical data trend for Greenbrook TMS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenbrook TMS Research & Development Chart

Greenbrook TMS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 1.47 0.53 0.86 0.66 0.53

Greenbrook TMS Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.11 0.14 0.17 0.12

Greenbrook TMS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.54 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Greenbrook TMS  (OTCPK:GBNHF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Greenbrook TMS Research & Development Related Terms

Thank you for viewing the detailed overview of Greenbrook TMS's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Greenbrook TMS (Greenbrook TMS) Business Description

Traded in Other Exchanges
N/A
Address
890 Yonge Street, 7th Floor, Toronto, ON, CAN, M4W 3P4
Greenbrook TMS Inc is a provider of Transcranial Magnetic Stimulation (TMS) therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, in the United States. TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. Greenbrook has provided over 11,00,000 TMS treatments to over 31,000 patients struggling with depression.

Greenbrook TMS (Greenbrook TMS) Headlines